---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-021548"
form_type: "8-K"
ticker: "DSS"
cik: "0000771999"
company_name: "DSS, INC."
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T23:20:44.385885+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# DSS converts $12M Impact Biomedical debt into 31.9M shares of Impact common stock

## Summary
- DSS settled all outstanding debt owed by Impact Biomedical under a $12M original note and amendments.
- In exchange, DSS received 31,939,778 freely tradeable shares of Impact's common stock.
- Transaction closed on July 21, 2025; issuance of shares constituted full satisfaction of amounts owed to DSS.

## SEC filing metadata
- accession: 0001641172-25-021548
- form_type: 8-K
- ticker: DSS
- cik: 0000771999
- company_name: DSS, INC.
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771999/000164117225021548/0001641172-25-021548-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771999/000164117225021548/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-021548
- JSON: https://secwatch.observer/filing/0001641172-25-021548.json
- Plain text: https://secwatch.observer/filing/0001641172-25-021548.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.